Ross Prentice, PhD, retired at the end of 2022 after working at Fred Hutchinson Cancer Center for nearly 50 years.
Dr. Prentice started at the center in 1974 "when the 'the Hutch' was little more than a twinkle in Bill Hutchinson's eye," he said in a Jan. 20 news release from the cancer center.
Dr. Prentice, a biostatistician, was the principal investigator of the Women's Health Initiative and served as Fred Hutch's senior vice president and director of the Public Health Sciences Division for more than 25 years. He is the first to propose the case-cohort study design and established the operational criteria for the use of surrogate endpoints in clinical trials, according to the release.
"His leadership in nutrition and health represent an inspiring example of the impact that a statistician may have by engaging deeply, consistently, and creatively in a scientific area and, where needed, taking on responsibilities beyond the data," Garnet Anderson, PhD, PHS director, said in the release.